Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
Resource Type
Article
Authors
He, Jianxing ; Su, Chunxia ; Liang, Wenhua ; Xu, Shidong ; Wu, Lin ; Fu, Xiangning ; Zhang, Xiaodong ; Ge, Di ; Chen, Qun ; Mao, Weimin ; Xu, Lin ; Chen, Chun ; Hu, Bing ; Shao, Guoguang ; Hu, Jian ; Zhao, Jian ; Liu, Xiaoqing ; Liu, Zhidong ; Wang, Zheng ; Xiao, Zemin ; Gong, Taiqian ; Lin, Wen ; Li, Xingya ; Ye, Feng ; Liu, Yang ; Ma, Haitao ; Huang, Yunchao ; Zhou, Jianying ; Wang, Zhonglin ; Fu, Junke ; Ding, Lieming ; Mao, Li ; Zhou, Caicun
Source
In The Lancet Respiratory Medicine September 2021 9(9):1021-1029
Subject
Primary Research Articles
Language
ISSN
2213-2600